Day 1: Friday, November 8, 2019











Plenary Session 1: Infection & Cancer Overview

Infectious causes of cancer: many opportunities for intervention

Doug Lowy, National Cancer Institute, Bethesda, USA


Title TBA 

Yuan Chang, University of Pittsburgh, Pittsburgh, USA


Title TBA 

Tak W. Mak, Princess Margaret Cancer Centre, University of Toronto, Canada and The University of Hong Kong, Hong Kong,China








Plenary Session 2: Experimental Models 
Leveraging orthotopic models of colon cancer to uncover disease mechanisms
Ömer H. Yilmaz, MIT Koch Institute for Integrated Cancer Research, Cambridge, USA


Title TBA
Xin Lu, University of Oxford, Oxford, UK

18:30-20:30Opening Reception & Poster Session A


Day 2: Saturday, November 9, 2019











Plenary Session 3: Prevention, Early Detection & Screening

Title TBA
Julia Brotherton, VCS Foundation, East Melbourne, Victoria, Australia


Screening for nasopharyngeal carcinoma using circulating EBV DNA
Dennis Lo, The Chinese University of Hong Kong, Hong Kong,China


Prevention of gastric cancer in H. pylori infected patients: Insights from population-based study
Wai Keung Leung, The University of Hong Kong, Hong Kong,China














Plenary Session 4: Molecular Pathology, Genetics
Title TBA
SY Leung, The University of Hong Kong, Hong Kong,China

Molecular pathology, genetics and genomics of HCC
Irene Ng, The University of Hong Kong, Hong Kong,China

Title TBA
Maura L. Gillison, The University of Texas MD Anderson Cancer Center, Houston, USA

Title TBA
KW Lo, Chinese University of Hong Kong, Hong Kong,China

13:00-14:30Poster Session B/Lunch










Plenary Session 5: Molecular Pathology, Epigenetics & Epidemiology
Epstein-Barr virus is an epigenetic driver of gastric cancer
Atsushi Kaneda, Chiba University, Japan

Epigenetic pathway of infection-induced cancer
Toshikazu Ushijima, National Cancer Center, Japan

Title TBA
Patrick Moore, University of Pittsburgh, Pittsburgh, PA, USA












Plenary Session 6: Molecular Pathology, Immunological Impact
Title TBA
Graham Taylor, Cancer Research UK Birmingham Centre, Birmingham,United Kingdom

Immune microenvironment of hepatitis B virus-related hepatocellular carcinoma
Valerie Chew, Translational Immunology Institute (TII), SingHealth-DukeNUS, Singapore

New Molecular Targets for Intervention in H. pylori-induced Gastric Inflammation and Carcinogenesis
Keith Wilson, Vanderbilt University Medical Center, Nashville, TN, USA


Day 3: Sunday, November 10, 2019










Plenary Session 7: Emerging Therapeutics I
Title TBA
Andrew Zhu, Massachusetts General Hospital, Boston, USA

Title TBA
Anthony Chan, Chinese University of Hong Kong, Hong Kong,China

Title TBA
Cornelis J.M. Melief, Leiden Univ. Medical Center & ISA Pharmaceuticals BV, Leiden, Netherlands











Plenary Session 8: Emerging Therapeutics II
T cell therapies targeting EBV and HPV positive malignancies
Helen Heslop, Baylor College of Medicine, USA

Immunotherapies for cancers attributable to infectious pathogens: Lessons learned from HPV
Cornelia Liu Trimble, The Johns Hopkins University School of Medicine, Baltimore, MD, USA

Title TBA
Cassian Yee, UT MD Anderson Cancer Center, Houston, TX, USA




Closing Keynote
Plasmidoses: Diseases linked to a novel class of human pathogens in common human cancers
Harald zur Hausen, German Cancer Research Center, Heidelberg, Germany